Sarcoidosis (Q39724): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/330792642
@@ Property / Canonical URI: https://id.who.int/icd/entity/330792642 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:4B20
@@ Property / CURIE: CID11:4B20 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-4B20
@@ Property / Canary Token: dki-india-4B20 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+D86.9
@@ Property / Linked ICD 10: D86.9 / rank @@
+Normal rank

Latest revision as of 05:14, 13 August 2026

Sarcoidosis is a multisystem disorder of unknown cause characterised by the formation of immune granulomas in involved organs. The lung and the lymphatic system are predominantly affected, but virtually every organ may be involved. Other severe manifestations result from cardiac, neurological, ocular, kidney or laryngeal localizations.

Language	Label	Description	Also known as
default for all languages	4B20
English	Sarcoidosis	Sarcoidosis is a multisystem disorder of unknown cause characterised by the formation of immune granulomas in involved organs. The lung and the lymphatic system are predominantly affected, but virtually every organ may be involved. Other severe manifestations result from cardiac, neurological, ocular, kidney or laryngeal localizations.